Log In
Print this Print this

AlloMap Molecular Expression Test

  Manage Alerts
Collapse Summary General Information
Company CareDx Inc.
DescriptionNon-invasive multi-gene expression profiling blood diagnostic
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationTransplant, Diagnostic
Indication DetailsIdentify heart transplant patients with stable allograft function who have a low probability of moderate/severe acute cellular rejection; Monitoring asymptomatic heart transplant patients for acute rejection after transplantation
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today